BF
Brighthouse Financial, Inc. (BHF)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 showed strong reported profitability: net income of $646 million ($10.79 diluted EPS) as GAAP MRB and derivative mark-to-market swung favorably; adjusted earnings were $304 million ($5.07) and $352 million ($5.88) excluding a $48 million unfavorable actuarial notable item .
- Capital actions stabilized statutory capital: combined RBC ratio was ~400% at year-end after a $100 million capital contribution to BLIC; holding company liquid assets remained robust at $1.1 billion ($1.0 billion pro forma) .
- Segment mix was resilient: Annuities adjusted earnings of $279 million (ex-notables higher sequentially on net investment income), Life improved to $52 million, while Run-off posted a $(27) million adjusted loss; corporate expenses fell 14% YoY to $210 million .
- Annuity sales softened (seasonal and product mix): $2.24 billion, down 11% sequentially and 5% YoY, while Life sales rose to $33 million; Shield RILA sales drove full-year records ($7.7B Shield; $10.0B total annuities; $120M life) .
- 2025 narrative catalysts: simplification of hedging (standalone for new Shield), reinsurance unlocking capital (UL/VUL deal added ~10–15 RBC points), and CFO outlook for relatively stable RBC without additional HoldCo support; rate steepening and legacy fixed annuity AAT sensitivity remain watch points .
What Went Well and What Went Wrong
-
What Went Well
- “Fully transitioning to hedging all new business for our Shield Level Annuities Product Suite on a standalone basis” and completing life reinsurance; RBC ~400% with $100 million BLIC contribution .
- Record 2024 sales: Shield RILA $7.7B, total annuities $10.0B, life $120M; “expense discipline” with corporate expenses down 7% YoY .
- Robust liquidity and capital returns: $1.1B HoldCo liquid assets at year-end and $250M 2024 buybacks ($60M in Q4) plus $25M repurchases through Feb 7, 2025 .
-
What Went Wrong
- Statutory TAC fell ~$300M in Q4 due to rates up ~80 bps and a significantly steeper curve; near-term hedge losses outweighed liability offsets under the statutory framework .
- Asset adequacy testing reserves rose by ~$200M tied to legacy fixed annuities with higher lapse sensitivity in high-rate scenarios, pressuring TAC .
- Annuity sales declined q/q and y/y, primarily from lower fixed deferred annuities despite record Shield sales; Run-off posted an adjusted loss of $(27)M .
Financial Results
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “We completed a reinsurance transaction… and fully transitioned to hedging all new business for our Shield Level Annuities… Our estimated combined RBC ratio… was approximately 400%… and we continue to have a robust level of holding company liquid assets.”
- CEO: “Record sales of our Shield Level Annuities Product Suite of $7.7 billion… and $120 million of life insurance sales for the full year.”
- CFO: “Our financial plan currently anticipates that our combined RBC ratio will be relatively stable over the next few years without additional support from the holding company.”
- CFO on Q4 drivers: “Interest rates were up approximately 80 bps… significant steepening… resulted in a negative impact on… statutory results… contributed to the $300 million decline in TAC… [and] a net $200 million increase in asset adequacy testing reserves.”
Q&A Highlights
- RBC dynamics: Strategic initiatives (reinsurance; Shield standalone hedging) added >$400M to positives, offset by rate/curve moves and $200M AAT, yielding ~400% RBC after $100M BLIC capital; UL/VUL reinsurance added ~10–15 RBC points .
- Legacy hedging and FCF timing: Back-book (legacy VA/Shield) hedging strategy in development; long-term statutory free cash flow disclosure timing likely slips until strategy finalized .
- Capital return and dividends: Plan contemplates subsidiary dividends to HoldCo after 2024; buybacks continued ($2.5B cumulative since 2018), with $25M repurchases early 2025 .
- Product outlook: Competitive RILA market; Shield enhancements (income riders; new crediting strategies) and continued sales momentum; FIA sales balanced with pricing and capital .
Estimates Context
- S&P Global consensus estimates for Q4 2024 EPS and revenue were unavailable at time of analysis due to a Capital IQ daily request limit. As a result, we cannot provide a beat/miss assessment versus Street for EPS/revenue this quarter.
- Benchmark for performance: Adjusted EPS less notable items was $5.88 and adjusted earnings less notable items were $352 million; GAAP diluted EPS was $10.79 driven by MRB/derivative volatility .
Key Takeaways for Investors
- Capital stability improved: Actions (life reinsurance, Shield standalone hedging, $100M capital to BLIC) anchored RBC ~400% with CFO signaling multi-year stability—supports valuation and capital return capacity .
- Earnings quality: Adjusted results ex-notables strengthened sequentially ($352M; $5.88), while GAAP remains volatile given MRB/derivative accounting—focus on adjusted trends and net investment income trajectory .
- Rate/curve sensitivity: Steepening yield curve can pressure near-term TAC via hedge marks; management expects benefits to accrue over time (mean reversion point increases)—watch rate path and curve shape .
- Legacy block execution risk: Timing of back-book hedging and long-term statutory FCF disclosures likely slips until strategy finalized—monitor 2025 updates .
- Growth engines intact: Shield RILA leadership, enhancements (income riders), and institutional LPP footprint (6 plans; $16B AUM) underpin medium-term sales, though fixed deferred annuities remain tactically constrained by capital/pricing .
- Expense discipline a tailwind: 7% YoY corporate expense reduction enhances adjusted profitability and ROCE ex-AOCI; priority remains sustaining low expense ratio .
- External ratings watch: AM Best revised issuer credit outlook to negative (FSR A affirmed), citing VA/RILA earnings drag and hedging complexity—continued delivery on capital initiatives should mitigate pressure over time .
Additional Context
- Preferred stock dividends declared for all four series with March 25, 2025 payment (Series A/B/C/D depositary shares) .
- Q3 confirmation: Approvals for the third-quarter annuity reinsurance transaction were received during the Q3 call; approximate deal size ~$8B .